2544|10000|Public
25|$|Evidence of {{impaired}} first-phase insulin release {{can be seen}} in the glucose tolerance test, {{demonstrated by}} a substantially elevated <b>blood</b> <b>glucose</b> <b>level</b> at 30 minutes after the ingestion of a glucose load (75 or 100 g of glucose), followed a slow drop over the next 100 minutes, to remain above 120mg/100 ml after two hours after the start of the test. In a normal person the <b>blood</b> <b>glucose</b> <b>level</b> is corrected (and may even be slightly over-corrected) by the end of the test.|$|E
25|$|The {{artificial}} pancreas is a technology in development {{to help people}} with diabetes automatically control their <b>blood</b> <b>glucose</b> <b>level</b> by providing the substitute endocrine functionality of a healthy pancreas.|$|E
25|$|Anatomic {{pathology}} {{relates to}} the processing, examination, and diagnosis of surgical specimens by a physician trained in pathological diagnosis. Clinical pathology is the division that processes the test requests more familiar to the general public; such as blood cell counts, coagulation studies, urinalysis, <b>blood</b> <b>glucose</b> <b>level</b> determinations and throat cultures. Its subsections include chemistry, hematology, microbiology, immunology, urinalysis and blood bank.|$|E
50|$|Glucagon {{increases}} <b>blood</b> <b>glucose</b> <b>levels,</b> and DPP-4 inhibitors reduce glucagon and <b>blood</b> <b>glucose</b> <b>levels.</b> The {{mechanism of}} DPP-4 inhibitors {{is to increase}} incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying, and decreases <b>blood</b> <b>glucose</b> <b>levels.</b>|$|R
3000|$|..., and <b>blood</b> <b>glucose</b> <b>levels,</b> but MRGlu {{increased}} with increasing <b>blood</b> <b>glucose</b> <b>levels</b> (Figure  4). Unlike that in MDA, SUV and K [...]...|$|R
40|$|Animals {{bearing a}} cachexia-inducing tumour, the MAC 16 adenocarcinoma, showed a {{progressive}} decrease in <b>blood</b> <b>glucose</b> <b>levels</b> with increasing weight loss, while animals bearing a histologically similar tumour, the MAC 13 adenocarcinoma, showed {{no change in}} either body weight or <b>blood</b> <b>glucose</b> <b>levels</b> with growth of the tumour. The effect of the MAC 16 tumour on <b>blood</b> <b>glucose</b> <b>levels</b> appeared to be unrelated to food intake, glucose consumption by the tumour, or {{to the production of}} increased levels of IGF-I and IGF-II mRNA by the tumour cells. The relationship between the induction of cachexia and alteration in <b>blood</b> <b>glucose</b> <b>levels</b> remains unknown...|$|R
25|$|Hunger is {{the result}} of a fall in <b>blood</b> <b>glucose</b> <b>level</b> or depriving cells of the ability to metabolize fatty acids—glucoprivation and lipoprivation, respectively, stimulate eating. Detectors in the brain are only {{sensitive}} to glucoprivation; detectors in the liver are sensitive to both glucoprivation and lipoprivation outside the blood–brain barrier. However, no single set of receptors is solely responsible for the information the brain uses to control eating.|$|E
25|$|When the {{glucose level}} {{comes down to}} the usual {{physiologic}} value, insulin release from the β-cells slows or stops. If the <b>blood</b> <b>glucose</b> <b>level</b> drops lower than this, especially to dangerously low levels, release of hyperglycemic hormones (most prominently glucagon from islet of Langerhans alpha cells) forces release of glucose into the blood from the liver glycogen stores, supplemented by gluconeogenesis if the glycogen stores become depleted. By increasing blood glucose, the hyperglycemic hormones prevent or correct life-threatening hypoglycemia.|$|E
25|$|The goal of islet {{transplantation}} is {{to infuse}} enough islets {{to control the}} <b>blood</b> <b>glucose</b> <b>level</b> removing the need for insulin injections. For an average-size person (70kg), a typical transplant requires about one million islets, isolated from two donor pancreases. Because good control of blood glucose can slow or prevent the progression of complications associated with diabetes, such as nerve or eye damage, a successful transplant may {{reduce the risk of}} these complications. But a transplant recipient will need to take immunosuppressive drugs that stop the immune system from rejecting the transplanted islets.|$|E
50|$|Hyperinsulinemia in {{neonates}} can be {{the result}} of a variety of environmental and genetic factors. If the mother of the infant is a diabetic, and does not properly control her <b>blood</b> <b>glucose</b> <b>levels,</b> the hyperglycemic maternal blood can create a hyperglycemic environment in the fetus. To compensate for the increased <b>blood</b> <b>glucose</b> <b>levels,</b> fetal pancreatic beta cells can undergo hyperplasia. The rapid division of beta cells results in increased levels of insulin being secreted to compensate for the high <b>blood</b> <b>glucose</b> <b>levels.</b> Following birth, the hyperglycemic maternal blood is no longer accessible to the neonate resulting in a rapid drop in the newborn’s <b>blood</b> <b>glucose</b> <b>levels.</b> As insulin levels are still elevated this may result in hypoglycemia. To treat the condition, high concentration doses of glucose are given to the neonate as required maintaining normal <b>blood</b> <b>glucose</b> <b>levels.</b> The hyperinsulinemia condition subsides after one to two days.|$|R
40|$|Background: {{uncontrolled}} {{diabetes mellitus}} will to complication of various Complications like stroke, hypertension, and heart disease. Complications {{due to increased}} production of free radical for high <b>blood</b> <b>glucose</b> <b>levels.</b> To keep <b>blood</b> <b>glucose</b> <b>levels</b> to normal, it necessary good consuming vitamins c. Vitamin c is necessary for diabetics mellitus to prevent oxidative and <b>blood</b> <b>glucose</b> <b>levels</b> in lowering triglycerides. objective: to know patterns of consumption vitamin c and <b>glucose</b> <b>levels</b> of triglyceride in the blood as in diabetes mellitus. Method: this study was observational with of cross sectional approach. Data consumption patterns of vitamin c, used food frequency (FFQ laboratories to examination and <b>blood</b> <b>glucose</b> <b>levels</b> and triglycerides. data analysis used spearman rank test. Results: of: intake of vitamin c from food and supplements of vitamin c was enough (98. 6...|$|R
30|$|Patients with {{diabetes}} should ceaselessly screen their <b>blood</b> <b>glucose</b> <b>levels</b> and modify insulin measurements, endeavouring to keep <b>blood</b> <b>glucose</b> <b>levels</b> as near typical {{as would be}} prudent [34]. <b>Blood</b> <b>glucose</b> <b>levels</b> that veer off from the typical range can prompt genuine here and now and long-haul intricacies. A programmed expectation shows that cautioned individuals of fast approaching changes in their <b>blood</b> <b>glucose</b> <b>levels</b> would empower {{them to make a}} preventive move. In this paper, we depict an answer that uses a bland physiological model of <b>blood</b> <b>glucose</b> progression to produce enlightening highlights for a support vector regression display that is prepared with tolerant particular information. The new model beats diabetes specialists at foreseeing <b>blood</b> <b>glucose</b> <b>levels</b> and could be utilized to envision right around a fourth of hypoglycaemic occasions 30  min ahead of time. In {{spite of the fact that}} the comparing exactness is right now only 42 %, most false cautions are in close hypoglycaemic locales and hence patients reacting to these hypoglycaemia alarms would not be hurt by intercession.|$|R
25|$|Insulin is {{produced}} in the pancreas and the Brockmann body (in some fish), and released when any of several stimuli are detected. These stimuli include ingested protein and glucose in the blood produced from digested food. Carbohydrates can be polymers of simple sugars or the simple sugars themselves. If the carbohydrates include glucose, then that glucose will be absorbed into the bloodstream and <b>blood</b> <b>glucose</b> <b>level</b> will begin to rise. In target cells, insulin initiates a signal transduction, which {{has the effect of}} increasing glucose uptake and storage. Finally, insulin is degraded, terminating the response.|$|E
25|$|In animals, {{this is a}} rate-controlling step of gluconeogenesis, {{the process}} by which cells {{synthesize}} glucose from metabolic precursors. The <b>blood</b> <b>glucose</b> <b>level</b> is maintained within well-defined limits in part due to precise regulation of PEPCK gene expression. To emphasize the importance of PEPCK in glucose homeostasis, over expression of this enzyme in mice results in symptoms of type II diabetes mellitus, by far {{the most common form of}} diabetes in humans. Due to the importance of blood glucose homeostasis, a number of hormones regulate a set of genes (including PEPCK) in the liver that modulate the rate of glucose synthesis.|$|E
25|$|Periodontitis {{has been}} linked to {{increased}} inflammation in the body, such as indicated by raised levels of C-reactive protein and interleukin-6. It is linked through this to increased risk of stroke, myocardial infarction, and atherosclerosis. It also linked in those over 60 years of age to impairments in delayed memory and calculation abilities. Individuals with impaired fasting glucose and diabetes mellitus have higher degrees of periodontal inflammation, and often have difficulties with balancing their <b>blood</b> <b>glucose</b> <b>level</b> owing to the constant systemic inflammatory state, caused by the periodontal inflammation. Although no causal association was proven, a recent study showed correlation between chronic periodontitis and erectile dysfunction.|$|E
40|$|Hemoglobin A 1 c (HbA 1 c) levels {{correlate}} closely, {{though not}} perfectly, with <b>blood</b> <b>glucose</b> <b>levels</b> {{in patients with}} diabetes (strength of recommendation [SOR]: A, based on systematic reviews). Correlation is higher for <b>blood</b> <b>glucose</b> <b>levels</b> {{later in the day}} than earlier in the day, higher for <b>blood</b> <b>glucose</b> <b>levels</b> in the most recent 30 days than from the prior 31 - 120 days, and higher for patients with type 2 diabetes compared with patients with type 1 diabetes (SOR: A, based on cohort studies) ...|$|R
50|$|GDM poses a risk {{to mother}} and child. This risk is largely related to {{uncontrolled}} high <b>blood</b> <b>glucose</b> <b>levels</b> and its consequences. The risk increases with higher <b>blood</b> <b>glucose</b> <b>levels.</b> Treatment resulting in better control of these levels can reduce some of the risks of GDM considerably.|$|R
40|$|This daily diary study {{investigated}} the emotional experiences and relationship behaviors of married couples coping with the husband's Type 2 diabetes, and how those experiences and behaviors affected his <b>blood</b> <b>glucose</b> <b>levels.</b> Repeated measures multilevel models {{examined the effects of}} husbands' and wives' absolute levels of positive and negative emotional experiences, balance of positive to negative emotional experiences, absolute levels of positive and negative behaviors, and balance of positive to negative behaviors on husbands' glucose. Husbands' negative emotional experience and wives' positive balance of relationship behaviors predicted lower <b>blood</b> <b>glucose</b> <b>levels.</b> For husbands who were younger, in poorer general health, and whose wives were more satisfied with their marriage, husbands' positive emotional experience predicted lower <b>blood</b> <b>glucose</b> <b>levels.</b> For husbands in better general health, wives' reports of a higher balance of positive as opposed to negative emotional experience also predicted lower <b>blood</b> <b>glucose</b> <b>levels.</b> Overall, results indicate that positive emotional experience and a balance of emotional experience and relationship behavior that is predominantly positive predicts positive diabetes outcomes as measured by lower daily <b>blood</b> <b>glucose</b> <b>levels...</b>|$|R
2500|$|... {{initiation}} {{of a combination}} bolus with the initial spike sized {{in proportion to the}} present <b>blood</b> <b>glucose</b> <b>level</b> and trends in the change of <b>blood</b> <b>glucose</b> <b>level,</b> ...|$|E
2500|$|... a bolus dose that {{is pumped}} to cover food eaten or {{to correct a}} high <b>blood</b> <b>glucose</b> <b>level.</b>|$|E
2500|$|Oral hypoglycemic agents (e.g., {{any of the}} sulfonylureas, {{or similar}} drugs, which {{increase}} insulin release from β-cells {{in response to a}} particular <b>blood</b> <b>glucose</b> <b>level)</b> ...|$|E
50|$|Frequent {{measurements}} of <b>blood</b> <b>glucose</b> <b>levels</b> were not used.|$|R
5000|$|... 1 hour {{postprandial}} capillary <b>blood</b> <b>glucose</b> <b>levels</b> <8.0 mmol/L ...|$|R
50|$|A {{common use}} is in {{relation}} to blood sugar (or <b>blood</b> <b>glucose)</b> <b>levels,</b> which are normally measured 2 hours after and before eating in a postprandial glucose test. This is because <b>blood</b> <b>glucose</b> <b>levels</b> usually rise after a meal. The American Diabetes Association recommends a postprandial <b>glucose</b> <b>level</b> under 180 mg/dl and a preprandial plasma glucose between 70-130 mg/dl.|$|R
2500|$|For instance, to {{determine}} an individual's morning basal requirement, they must skip breakfast. On waking, they would test their <b>blood</b> <b>glucose</b> <b>level</b> periodically until lunch. Changes in <b>blood</b> <b>glucose</b> <b>level</b> are compensated with adjustments {{in the morning}} basal rate. [...] The process is repeated over several days, varying the fasting period, until a 24-hour basal profile has been built up which keeps fasting blood sugar levels relatively steady. Once the basal rate is matched to the fasting basal insulin need, the pump user will then gain the flexibility to skip or postpone meals such as sleeping late on the weekends or working overtime on a weekday.|$|E
2500|$|... {{when the}} blood sugar is decreasing, the basal rate can be halted {{to deny the}} {{quantity}} of insulin needed to bring the <b>blood</b> <b>glucose</b> <b>level</b> back up until the basal rate can be continued at a new lower rate; ...|$|E
2500|$|The {{first step}} in {{controlling}} an insulin pump based on continuous blood glucose data is to automatically control the basal rate of the insulin pump. [...] When a bolus has not recently been performed, the pump can manage the <b>blood</b> <b>glucose</b> <b>level</b> by adjusting the basal rate as needed: ...|$|E
40|$|This {{study was}} planned to {{investigate}} the effects of supplementation of cinnamon on fasting <b>blood</b> <b>glucose</b> <b>levels</b> and lipid profiles among type 2 diabetic patients. 60 subjects with type 2 diabetes from both sexes (30 males and 30 females) were allocated to the intervention and control groups (30 individuals per group). The doses of 1. 5 g of cinnamon were equally administered orally {{in the form of}} cinnamon powder into 500 mg per capsule with breakfast, lunch, and dinner for 60 days. Control group received capsules of containing placebo. Blood samples were obtained on the beginning day of the experiment {{and at the end of}} 60 days. The fasting <b>blood</b> <b>glucose</b> <b>levels</b> and lipid profiles including total cholesterol, LDL-C, HDL-C and triglycerides of types 2 subjects were measured. Fasting <b>blood</b> <b>glucose</b> <b>levels</b> and lipid profiles in intervention group were significantly lower than control group (p< 0. 05). The average of fasting <b>blood</b> <b>glucose</b> <b>levels,</b> total cholesterol, cholesterol LDL and triglyceride levels were decreased after consumption of cinnamon powder, significantly(p< 0. 05). We observed no significant changes in fasting <b>blood</b> <b>glucose</b> <b>levels</b> and lipid profiles after consumption of placebo in control group. Conclusion: This study showed that consumption of cinnamon supplementation may be useful in control and decreasing of fasting <b>blood</b> <b>glucose</b> <b>levels</b> and lipid profiles among type 2 diabetes individuals...|$|R
25|$|Hypoglycemics, {{acetazolamide}} {{can both}} {{increase or decrease}} <b>blood</b> <b>glucose</b> <b>levels.</b>|$|R
2500|$|... low normal <b>blood</b> <b>glucose</b> <b>levels</b> (glycosylated hemoglobin, {{also called}} HbA1c); ...|$|R
2500|$|Glucagon rescue is the {{emergency}} injection of glucagon {{in case of}} severe diabetic hypoglycemia. It is needed during seizures and/or unconsciousness by an insulin user who is unable at that point to help themselves. [...] Glucagon will facilitate the release of stored glucose back into the bloodstream, raising the <b>blood</b> <b>glucose</b> <b>level.</b>|$|E
2500|$|Glucose {{reduction}} {{is not the}} major glucose metabolism pathway in a normal human body, where the glucose level is in the normal range. However, in diabetic patients whose <b>blood</b> <b>glucose</b> <b>level</b> is high, up to 1/3 of their glucose could go through the glucose reduction pathway. This will consume NADH and eventually leads to cell damage.|$|E
2500|$|When insulin pump {{technology}} {{is combined with}} a continuous blood glucose monitoring system, the technology seems promising for real-time control of the blood sugar level. [...] Currently there are no mature algorithms to automatically control the insulin delivery based on feedback of the <b>blood</b> <b>glucose</b> <b>level.</b> [...] When the loop is closed, the system may function as an artificial pancreas.|$|E
5000|$|Hypoglycemics, {{acetazolamide}} {{can both}} {{increase or decrease}} <b>blood</b> <b>glucose</b> <b>levels.</b>|$|R
5000|$|... low normal <b>blood</b> <b>glucose</b> <b>levels</b> (glycosylated hemoglobin, {{also called}} HbA1c); ...|$|R
40|$|Patients with {{diabetes}} must continually monitor their <b>blood</b> <b>glucose</b> <b>levels</b> and adjust insulin doses, striving to keep <b>blood</b> <b>glucose</b> <b>levels</b> {{as close to}} normal as pos-sible. <b>Blood</b> <b>glucose</b> <b>levels</b> that deviate from the normal range can lead to serious short-term and long-term com-plications. An automatic prediction model that warned people of imminent changes in their <b>blood</b> <b>glucose</b> lev-els {{would enable them to}} take preventive action. In this paper, we describe a solution that uses a generic phys-iological model of <b>blood</b> <b>glucose</b> dynamics to generate informative features for a Support Vector Regression model that is trained on patient specific data. The new model outperforms diabetes experts at predicting <b>blood</b> <b>glucose</b> <b>levels</b> and could be used to anticipate almost a quarter of hypoglycemic events 30 minutes in advance. Although the corresponding precision is currently just 42 %, most false alarms are in near-hypoglycemic re-gions and therefore patients responding to these hypo-glycemia alerts would not be harmed by intervention...|$|R
